Raymond James Financial Services Advisors, Inc. has a $6.19 million equity position in InMode Ltd. (NASDAQ:INMD).

Financial Advisors


Raymond James Financial Services Advisors Inc. reduced its position in Inmode (NASDAQ:INMD – Valuation Acquisition) by 2.1% in the fourth quarter, according to its latest filing with the Securities and Exchange Commission. . The company owned 173,423 shares in the healthcare company after selling 3,728 shares during the period. Raymond James Financial Services Advisors held approximately 0.21% of Inmode’s shares, valued at $6,191,000, at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently changed positions in the company. Knuff & Co LLC landed him a new position worth $33,000 on his InMode in the third quarter. Parallel Advisors LLC increased his InMode stake by 9,263.6% in the fourth quarter. Parallel Advisors LLC now owns 1,030 shares of the healthcare company, valued at $37,000, after purchasing an additional 1,019 of his shares during the period. Belpointe Asset Management LLC acquired a new position worth $37,000 in InMode in the fourth quarter. Brown Brothers Harriman & Co. won a new position worth $41,000 in InMode in the first quarter. Finally, Toth Financial Advisory Corp increased his InMode stake by 80.0% in the fourth quarter. Toth Financial Advisory Corp now owns 1,350 shares of the healthcare company worth $48,000 after purchasing an additional 600 shares during the period. Institutional investors and hedge funds hold 55.24% of the company’s shares.

Analyst Rating Change

A number of equity analysts have recently voiced their opinion on stock prices. Barclays raised its price target on in-mode shares to $47.00 from $45.00 in a research note on Thursday, May 4. Needham & Company LLC downgraded Inmod stock from a ‘buy’ rating to a ‘hold’ rating in a research note on Friday, February 17. On Wednesday, April 19, TheStreet upgraded InMode’s stock from a ‘c+’ rating to a ‘b-‘ rating in a research note. Finally, UBS Group began reporting on InMode shares in a research note on Tuesday, March 28. They rated the company Buy and set a target price of $40.00. One investment analyst rated the stock as a hold, while five rated it as a buy. According to MarketBeat, the company has a consensus rating of “moderate buy” and a consensus price target of $45.71.

In-mod stock performance

INMD shares opened Thursday at $32.98. Its 50-day moving average is $33.65 and its 200-day moving average is $34.91. The stock has a market cap of $2.74 billion, a price/earnings multiple of 16.41, and a beta of 2.07. InMode Ltd. reached a 52-week low of $21.20 and a 52-week high of $41.84.

InMode (NASDAQ:INMD – Get Rating) last reported earnings on Tuesday, February 14th. The healthcare company reported earnings per share (EPS) of $0.69 for the quarter, beating analyst consensus expectations of $0.72 ($0.03). The company’s revenue for the quarter was $133.57 million. InMode’s net profit margin was 36.05% and return on equity was 36.35%. Sell-side analysts forecast InMode Ltd’s EPS to be 2.43 for the current financial year.

About inmode

(get rating)

InMode Ltd. designs, develops, manufactures and markets in the United States and internationally minimally invasive aesthetic medicine products based on proprietary radiofrequency-assisted lipolysis and deep subcutaneous fractional radiofrequency technologies. The company offers minimally invasive aesthetic medicine products for use in women’s health conditions and procedures, including simultaneous skin tightening liposuction, body and facial contouring, and skin rejuvenation treatments.

Featured Stories

InMode Quarterly Institutional Ownership (NASDAQ:INMD)

This instant news alert was generated by MarketBeat’s narrative science technology and financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments regarding this story to contact@marketbeat.com.

Listen to this before considering InMode.

MarketBeat tracks Wall Street’s highest-rated, highest-performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks that top analysts are secretly whispering to customers to buy now before the market as a whole rises…and InMode wasn’t on that list.

Inmode currently has a “moderate buy” rating among analysts, although high-scoring analysts think these five stocks are better buys.

Click here for 5 brands

Cover of Best High Dividend Stocks of 2023



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *